Shionogi Expands Cancer Vaccine Licensing With Oncotherapy Science
This article was originally published in PharmAsia News
Executive Summary
Shionogi & Co. Ltd. March 29 signed a worldwide licensing agreement with Kawasaki-based OncoTherapy Science, Inc (OTS) to develop, manufacture and market cancer peptide vaccines.